STRENGTHS AND LIMITATIONS OF THIS STUDY
syncope
The ASPIRED trial uses non-blinded randomisation to compare immediate enhanced ambulatory ECG monitoring versus standard monitoring in acute unexplained syncope patients.The primary outcome measure is a patient focussed measure very relevant to the population of patients who suffer syncope.We are using health economic analysis and a separate embedded qualitative study to assess the wider implications of using immediate enhanced ambulatory ECG monitoring in this population.In contrast to the few published studies on ambulatory monitoring in syncope patients which are generally single centred, without any comparative group and with heterogeneous patient populations and device capabilities, this study is multicentred and includes a standard care group.